Construction and Validation of a Nomogram to Predict Overall Survival in Very Young Female Patients with Curatively Resected Breast Cancer

References

• SungH, FerlayJ, SiegelRL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.2166033538338
   PubMed Web of Science ®Google Scholar
• ChenW, ZhengR, BaadePD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• FanL, Strasser-WeipplK, LiJJ, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–289. doi:10.1016/S1470-2045(13)70567-924872111
   PubMed Web of Science ®Google Scholar
• AndersCK, HsuDS, BroadwaterG, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324–3330. doi:10.1200/JCO.2007.14.247118612148
   PubMed Web of Science ®Google Scholar
• NarodSA. Breast cancer in young women. Nat Rev Clin Oncol. 2012;9(8):460–470. doi:10.1038/nrclinonc.2012.10222733233
   PubMed Web of Science ®Google Scholar
• LeclereB, MolinieF, TretarreB, et al. Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol. 2013;37(5):544–549. doi:10.1016/j.canep.2013.05.00123768969
   PubMed Web of Science ®Google Scholar
• JohnsonRH, ChienFL, BleyerA. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013;309(8):800–805. doi:10.1001/jama.2013.77623443443
   PubMed Web of Science ®Google Scholar
• PlichtaJK, RenY, ThomasSM, et al. Implications for breast cancer restaging based on the 8th Edition AJCC staging manual. Ann Surg. 2020;271(1):169–176. doi:10.1097/SLA.000000000000307130312199
   PubMed Web of Science ®Google Scholar
• GiulianoAE, EdgeSB, HortobagyiGN. Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. 2018;25(7):1783–1785. doi:10.1245/s10434-018-6486-629671136
   PubMed Web of Science ®Google Scholar
• IasonosA, SchragD, RajGV, PanageasKS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.979118323559
   PubMed Web of Science ®Google Scholar
• LiN, ZhongQQ, YangXR, et al. Prognostic value of hepatitis B virus infection in very young patients with curatively resected breast cancer: analyses from an endemic area in China. Front Oncol. 2020;10:1403. doi:10.3389/fonc.2020.0140332850453
   PubMed Web of Science ®Google Scholar
• AzimHAJr, PartridgeAH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16(4):427. doi:10.1186/s13058-014-0427-525436920
   PubMed Web of Science ®Google Scholar
• EirizIF, Vaz BatistaM, Cruz TomasT, NevesMT, Guerra-PereiraN, BragaS. Breast cancer in very young women-a multicenter 10-year experience. ESMO Open. 2021;6(1):100029. doi:10.1016/j.esmoop.2020.10002933399090
   PubMed Web of Science ®Google Scholar
• SingletarySE, ConnollyJL. Breast cancer staging: working with the sixth edition of the AJCC cancer staging manual. CA Cancer J Clin. 2006;56(1):37–47; quiz 50–31. doi:10.3322/canjclin.56.1.37
   PubMed Web of Science ®Google Scholar
• CampRL, Dolled-FilhartM, RimmDL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-071315534099
   PubMed Web of Science ®Google Scholar
• ReinerAS, WattGP, JohnEM, et al. Smoking, radiation therapy, and contralateral breast cancer risk in young women. J Natl Cancer Inst. 2021. doi:10.1093/jnci/djab047
   Google Scholar
• AndersCK, JohnsonR, LittonJ, PhillipsM, BleyerA. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237–249. doi:10.1053/j.seminoncol.2009.03.00119460581
   PubMed Web of Science ®Google Scholar
• DeSantisCE, MaJ, Goding SauerA, NewmanLA, JemalA. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439–448. doi:10.3322/caac.2141228972651
   PubMed Web of Science ®Google Scholar
• KmietowiczZ. Young black UK women are less likely than young white women to survive breast cancer. BMJ. 2013;347:f6413. doi:10.1136/bmj.f641324153245
   PubMedGoogle Scholar
• SorlieT, PerouCM, TibshiraniR, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–10874. doi:10.1073/pnas.19136709811553815
   PubMed Web of Science ®Google Scholar
• GoutsouliakK, VeeraraghavanJ, SethunathV, et al. Towards personalized treatment for early stage HER2-positive breast cancer. Nat Rev Clin Oncol. 2020;17(4):233–250. doi:10.1038/s41571-019-0299-931836877
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351(9114):1451–1467. doi:10.1016/S0140-6736(97)11423-49605801
   PubMed Web of Science ®Google Scholar
• StendahlM, RydenL, NordenskjoldB, JonssonPE, LandbergG, JirstromK. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res. 2006;12(15):4614–4618. doi:10.1158/1078-0432.CCR-06-024816899609
   PubMed Web of Science ®Google Scholar
• YangWT, BuH. [Updates in the 5(th) edition of WHO classification of tumours of the breast]. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):400–405. (Chinese).32392923
   PubMedGoogle Scholar
• ZhangH, ZhangN, MoranMS, et al. Special subtypes with favorable prognosis in breast cancer: a registry-based cohort study and network meta-analysis. Cancer Treat Rev. 2020;91:102108. doi:10.1016/j.ctrv.2020.10210833075683
   PubMed Web of Science ®Google Scholar
• KehlKL, GiordanoSH. BRCA1 and BRCA2 testing among young breast cancer survivors. JAMA Oncol. 2016;2(5):688–689. doi:10.1001/jamaoncol.2016.097627244682
   PubMed Web of Science ®Google Scholar
• LigibelJA, CirrincioneCT, LiuM, et al. Body mass index, PAM50 subtype, and outcomes in node-positive breast cancer: CALGB 9741 (Alliance). J Natl Cancer Inst. 2015;107(9). doi:10.1093/jnci/djv179
   Google Scholar